Evidence map›Paper›PMID 35859440›Full record

ArticleThe Indian journal of medical research2022

Peripheral lymphocyte subset alteration in patients with COVID-19 having differential clinical manifestations.

Anuradha S Tripathy, Diptee Trimbake, Poonam V Suryawanshi, Srikanth P Tripathy, Yogesh K Gurav, Varsha A Potdar, Manohar L Chaudhary, Prachi Athavale, Nitin D Mokashi, Sudhir D Patsute and 2 more

Open access · diamondAbstract read
In one paragraph

Article in The Indian journal of medical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Anuradha S TripathyHepatitis Group, ICMR- National Institute of Virology, Pune, Maharashtra, India.
Diptee TrimbakeHepatitis Group, ICMR- National Institute of Virology, Pune, Maharashtra, India.
Poonam V SuryawanshiDr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, Maharashtra, India.
Srikanth P TripathyDr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, Maharashtra, India.
Yogesh K GuravEpidemiology Group, ICMR- National Institute of Virology, Pune, Maharashtra, India.
Varsha A PotdarInfluenza group, ICMR- National Institute of Virology, Pune, Maharashtra, India.
Manohar L ChaudharyInfluenza group, ICMR- National Institute of Virology, Pune, Maharashtra, India.
Prachi AthavaleDepartment of Microbiology, Dr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, Maharashtra, India.
Nitin D MokashiDepartment of Microbiology, Yashwantrao Chavan Hospital, Pimpri Chinchwad Municipal Corporation, Pune, Maharashtra, India.
Sudhir D PatsuteNaidu Hospital, Pune Municipal Corporation, Pune, Maharashtra, India.
Arjun L KakraniDr. D. Y. Patil Medical College, Hospital & Research Centre, Pune, Maharashtra, India.
Priya AbrahamICMR- National Institute of Virology, Pune, Maharashtra, India.
Dr. D. Y. Patil Medical College, Hospital and Research Centre · INICMR-National Institute of Virology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & objectives: The COVID-19 disease profile in Indian patients has been found to be different from the Western world. Changes in lymphocyte compartment have been correlated with disease course, illness severity and clinical outcome. This study was aimed to assess the peripheral lymphocyte phenotype and subset distribution in patients with COVID-19 disease from India with differential clinical manifestations. Methods: Percentages of peripheral lymphocyte subsets were measured by flow cytometry in hospitalized asymptomatic (n=53), mild symptomatic (n=36), moderate and severe (n=30) patients with SARS-CoV-2 infection, recovered individuals (n=40) and uninfected controls (n=56) from Pune, Maharashtra, India. Results: Percentages of CD4+Th cells were significantly high in asymptomatic, mild symptomatic, moderate and severe patients and recovered individuals compared to controls. Percentages of Th memory (CD3+CD4+CD45RO+), Tc memory (CD3+CD8+CD45RO+) and B memory (CD19+CD27+) cells were significantly higher in the recovered group compared to both asymptomatic, mild symptomatic patient and uninfected control groups. NK cell (CD56+CD3-) percentages were comparable among moderate +severe patient and uninfected control groups. Interpretation & conclusions: The observed lower CD4+Th cells in moderate+severe group requiring oxygen support compared to asymptomatic+mild symptomatic group not requiring oxygen support could be indicative of poor prognosis. Higher Th memory, Tc memory and B memory cells in the recovered group compared to mild symptomatic patient groups might be markers of recovery from mild infection; however, it remains to be established if the persistence of any of these cells could be considered as a correlate of protection.

Indexed as

COVID-19HumansIndiaLymphocyte CountLymphocyte SubsetsOxygenSARS-CoV-2OxygenAsymptomaticlymphocyte subsetmild symptomaticmoderate +severe patientsrecovered individualsSARS-CoV-2

Identifiers

PMID35859440
PMCPMC9552374
OpenAlexW4286598747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.